Amid Criticism Over Unaffordable Insulin, Lilly Strikes a Manufacturing Deal to Supply Africa

Eli Lilly’s manufacturing agreement aimed at boosting insulin access in Africa is “largely a symbolic drop in the bucket,” Professor Brook Baker, senior policy analyst for Health GAP, tells STAT.